Clinical Trial Update: Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating finotonlimab in combination with stapokibart for recurrent/metastatic head and neck squamous cell carcinoma; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Finotonlimab
• Stapokibart

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: HNSCC | Phase 1 | Status: NOT_YET_RECRUITING